Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

[Full Text]
Displaying Investigations 1 to 33 of 33 found
From 3 References


Hu et al 2018, Nucleic Acids Res
  Adenocarcinoma Prostate
AKAP10/GID4
t(17;17)(p11;p11)
  Squamous cell carcinoma Uterus, cervix
ALKBH5/GID4
t(17;17)(p11;p11)
  Adenocarcinoma Prostate
EPN2/SLC5A10
t(17;17)(p11;p11)
  Transitional cell carcinoma Bladder
EPN2/MAP2K3
t(17;17)(p11;p11)
  Adenocarcinoma Oesophagus
FAM83G/B9D1
t(17;17)(p11;p11)
  Mesenchymal tumor, NOS Unknown site
FLCN/COPS3
t(17;17)(p11;p11)
  Adenocarcinoma Breast
LRRC75A/PEMT
t(17;17)(p11;p11)
  Adenocarcinoma Kidney
MPRIP/COPS3
t(17;17)(p11;p11)
  Mesenchymal tumor, NOS Unknown site
MPRIP/TNFRSF13B
t(17;17)(p11;p11)
  Transitional cell carcinoma Bladder
MPRIP/TOM1L2
t(17;17)(p11;p11)
  Adenocarcinoma Breast
NCOR1/ZNF287
t(17;17)(p11;p11)
  Adenocarcinoma Large intestine
NCOR1/PIGL
t(17;17)(p11;p11)
  Adenocarcinoma Prostate
PEMT/TOP3A
t(17;17)(p11;p11)
  Adenocarcinoma Kidney
SLC47A2/ULK2
t(17;17)(p11;p11)
  Mesenchymal tumor, NOS Unknown site
SLC47A2/SPECC1
t(17;17)(p11;p11)
  Astrocytoma, grade I-II Brain
SLC47A2/ALDH3A1
t(17;17)(p11;p11)
  Transitional cell carcinoma Bladder
SREBF1/MED9
t(17;17)(p11;p11)
  Mesenchymal tumor, NOS Unknown site
TNFRSF13B/MPRIP
t(17;17)(p11;p11)

Robinson et al 2017, Nature
  Liposarcoma, dedifferentiated Soft tissue
NCOR1/MAPK7
t(17;17)(p11;p11)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Thyroid
LLGL1/ALKBH5
t(17;17)(p11;p11)
  Astrocytoma, grade I-II Brain
B9D1/EPN2
t(17;17)(p11;p11)
  Squamous cell carcinoma Oral cavity
PEMT/RAI1
t(17;17)(p11;p11)
  Squamous cell carcinoma Oral cavity
RAI1/PEMT
t(17;17)(p11;p11)
  Squamous cell carcinoma Oral cavity
FAM83G/GRAP
t(17;17)(p11;p11)
  Squamous cell carcinoma Oral cavity
TOM1L2/ATPAF2
t(17;17)(p11;p11)
  Adenocarcinoma Breast
MYO15A/TOP3A
t(17;17)(p11;p11)
  Adenocarcinoma Breast
DRG2/ZNF624
t(17;17)(p11;p11)
  Adenocarcinoma Breast
TOM1L2/ULK2
t(17;17)(p11;p11)
  Adenocarcinoma Breast
SREBF1/LRRC48
t(17;17)(p11;p11)
  Adenocarcinoma Breast
EPN2/AKAP10
t(17;17)(p11;p11)
  Adenocarcinoma Breast
NCOR1/ZNF287
t(17;17)(p11;p11)
  Adenocarcinoma Breast
SPECC1/TMEM11
t(17;17)(p11;p11)
  Transitional cell carcinoma Bladder
EPN2/KCNJ12
t(17;17)(p11;p11)